Tinnitus Types: Medication-Induced Tinnitus

Some drugs, including aspirin, certain antibiotics and diuretics, can trigger or worsen tinnitus. Which medications to watch out for.

  • When Tinnitus Suddenly Stops: What It Means and Whether It Will Last

    When Tinnitus Suddenly Stops: What It Means and Whether It Will Last

    My Tinnitus Suddenly Stopped: What Does It Mean?

    The moment tinnitus goes quiet can feel surreal. After days, months, or even years of constant ringing, buzzing, or hissing, silence arrives without warning. For most people, the first reaction is a mixture of cautious relief and immediate worry: Is it really gone? Will it come back if I think about it too hard? Those questions are worth taking seriously, and this article answers both of them as honestly as the evidence allows.

    If your tinnitus has suddenly stopped, you are most likely experiencing one of two things: true physiological resolution, where an underlying reversible cause has cleared, or habituation, where the brain has learned to suppress the signal. The difference between the two largely determines whether the silence will last. In physiological resolution, the peripheral source of the problem (an infection, a wax blockage, a medication) has been corrected, and the auditory system no longer generates the phantom signal. In habituation, the signal may still be present at some level, but the brain’s attentional and emotional systems have stopped flagging it as important, so it fades from conscious awareness. Both are genuine improvements. They just have different implications for durability.

    The Most Common Reasons Tinnitus Stops

    When tinnitus disappears and stays gone, the most likely explanation is that whatever was generating the signal in the first place has resolved. Several reversible causes are well established.

    Ear infection clearing. Otitis media (middle ear infection) and outer ear infections cause fluid buildup or inflammation that disrupts normal sound conduction and can trigger tinnitus. When the infection clears, the mechanical disturbance resolves and the tinnitus typically stops with it.

    Earwax removal. A buildup of earwax can press against the eardrum or occlude the ear canal, creating a low-frequency tonal or rushing sound. Irrigation or microsuction (a gentle suctioning procedure performed by a clinician) removes the physical blockage, and tinnitus often stops within hours or days.

    Noise-induced acute episode fading. After a single loud noise exposure (a concert, a firecracker, a gunshot), many people notice ringing or muffled hearing. This type of acute noise-induced tinnitus typically resolves within 16 to 48 hours as the cochlear hair cells (the sensory cells in the inner ear that convert sound vibrations into nerve signals) recover from temporary threshold shift (a short-term reduction in hearing sensitivity caused by noise exposure). If you are reading this the morning after a loud event and your ears are still ringing, there is a good chance it will fade by tomorrow. For many people with acute tinnitus after a loud event, the sound went away on its own within a day or two.

    Medication change. A range of medications, including high-dose aspirin, certain antibiotics, loop diuretics (water pills used to reduce fluid retention, such as furosemide), and some chemotherapy agents, are ototoxic (capable of damaging the inner ear or hearing) at sufficient doses. When the offending drug is stopped or reduced, tinnitus can resolve, sometimes within days.

    Blood pressure normalisation. Pulsatile tinnitus (a rhythmic sound that matches the heartbeat) is sometimes driven by turbulent blood flow near the ear. When high blood pressure or a vascular irregularity is treated, the mechanical source of the signal disappears.

    Eustachian tube dysfunction resolving. The Eustachian tube regulates pressure in the middle ear. When it becomes blocked (from a cold, allergy, or altitude change), pressure imbalances can cause tinnitus. Once the tube opens and pressure equalises, the symptom often stops.

    In each of these cases, the body has addressed the peripheral driver of tinnitus. No driver, no signal.

    When the Brain Silences Tinnitus: What Habituation Actually Means

    Not all tinnitus relief is peripheral. A significant portion of the improvement people experience over time reflects something happening in the brain rather than in the ear.

    A 2025 longitudinal study tracked a community-based sample of people from acute tinnitus onset (under 6 weeks) through 6 months, measuring both their subjective distress and objective auditory sensitivity at each point. Tinnitus Handicap Inventory (THI) and Tinnitus Functional Index (TFI) scores — standardised questionnaires that measure how much tinnitus affects daily functioning and distress — dropped substantially over time. Objective measures of auditory sensitivity did not change at all. The ears were not recovering. The brain was adapting (Abishek et al., 2025).

    This process is called habituation. According to the Jastreboff neurophysiological model of tinnitus, widely cited in the research literature, tinnitus distress is thought to involve the limbic and autonomic systems (the brain networks involved in emotional processing and the stress response) classifying the tinnitus signal as threatening or significant. Over time, if the signal is consistently non-harmful, these systems can reclassify it as unimportant, and it stops reaching conscious awareness. The signal may still be there at a neural level, but the brain stops surfacing it. This is a theoretical framework, and while full verification awaits further research, it is consistent with the Abishek et al. 2025 findings described above.

    This explains why tinnitus can feel like it has “suddenly” stopped even in cases where no peripheral change has occurred. The shift is real and meaningful. It is not a trick. Under certain conditions (stress, fatigue, a very quiet room at night), the signal can re-emerge, at least temporarily. This is not a sign of failure or relapse. It reflects the nature of attentional processing. The good news from Abishek et al. (2025) is that distress scores peak at onset and decline substantially in the first six months for most people, which means the window for habituation to take hold is real and relatively near-term.

    The distinction between peripheral resolution and central habituation often cannot be cleanly determined from the outside. Both can produce the same sudden subjective silence. The difference matters when you ask: will it last?

    Tinnitus Remission by Duration: How to Read the Prognosis

    The single most useful piece of information for interpreting sudden tinnitus silence is how long the tinnitus had been present before it stopped.

    Acute tinnitus (under 3 months). This is the window of greatest natural recovery potential. Some secondary sources suggest roughly 70% of acute tinnitus cases may resolve spontaneously, though this estimate lacks a directly verified primary study behind it. For one well-studied group, people who developed tinnitus following mild-to-moderate sudden sensorineural hearing loss (ISSNHL), the remission rate reached approximately 67% within 3 months (Mühlmeier et al., 2016). Remission was consistently preceded by hearing recovery, reinforcing the peripheral-to-central chain: when cochlear damage repairs, the brain’s compensatory amplification of auditory signals normalises and the tinnitus resolves.

    For severe-to-profound hearing loss cases in the same study, the picture was less positive: fewer than one in four (approximately 22.7%) achieved full tinnitus remission (Mühlmeier et al., 2016). For people who presented late (more than 30 days after onset), complete remission rates fell below 20%, regardless of hearing loss severity.

    One important caveat: the Mühlmeier data applies specifically to ISSNHL-related tinnitus. Remission rates for noise-induced, medication-induced, or idiopathic tinnitus may differ.

    Subacute tinnitus (3 to 6 months). Tinnitus that persists beyond the acute phase becomes progressively less likely to fully resolve on its own. Research suggests that approximately 88 to 90% of acute tinnitus cases that do not resolve early go on to become chronic (Schlee et al., 2020). This does not mean improvement stops, but it does shift the likely mechanism from peripheral resolution toward central habituation.

    Chronic tinnitus (beyond 6 months). Spontaneous full remission still occurs. Research suggests that perhaps 20 to 30% of people with chronic tinnitus experience meaningful improvement or full remission over several years, though precise estimates vary across studies. For chronic tinnitus, the realistic goal shifts from expecting the signal to disappear entirely to achieving sustained habituation, where the sound no longer causes significant distress, even if it is occasionally audible.

    The persistent belief, sometimes communicated by healthcare providers, that tinnitus lasting beyond 6 months is permanent, is not supported by the evidence. Late remission happens. It becomes less probable, and the mechanism is more likely attentional than peripheral.

    When Sudden Silence Is a Warning Sign to Take Seriously

    Most of the time, tinnitus stopping is straightforwardly good news. There is one situation, though, where sudden silence warrants a call to your doctor rather than a sigh of relief.

    If tinnitus stops in one ear only, and this is accompanied by new hearing loss in that ear, a feeling of fullness or pressure, or any neurological symptoms such as sudden dizziness, facial weakness, or changes in vision, seek prompt medical evaluation. The concern here is sudden sensorineural hearing loss (SSNHL), which can present alongside or after tinnitus and requires rapid assessment. An audiometric evaluation (a hearing test) should be arranged without delay in such cases; if neurological symptoms are also present, same-day evaluation is appropriate.

    The tinnitus stopping is not itself the warning sign. The accompanying symptoms are. If your tinnitus has gone quiet and you feel completely well, there is no reason for alarm. If the silence in one ear came with other changes, it is worth getting checked.

    Key Takeaways

    After sudden tinnitus silence, here is what the evidence actually supports:

    • Tinnitus stops through two distinct mechanisms: physiological resolution (a peripheral cause has cleared) or habituation (the brain has stopped prioritising the signal). Both are real improvements.
    • How long the tinnitus lasted before it stopped is the most useful guide to whether the silence will hold. Acute tinnitus (under 3 months) has the highest remission potential.
    • For people who developed tinnitus after mild-to-moderate sudden hearing loss, roughly 67% achieved complete remission within 3 months (Mühlmeier et al., 2016). Late presenters had remission rates below 20%.
    • Chronic tinnitus (beyond 6 months) can still improve. Research suggests perhaps 20 to 30% of people with chronic tinnitus experience meaningful improvement or full remission over several years, with sustained habituation being the more common successful outcome.
    • If tinnitus stops in one ear alongside new hearing loss, pressure, or neurological symptoms, see a doctor.

    Sudden silence, whatever produced it, is worth taking seriously as a sign of real improvement for most people. The evidence backs that hope, even when it cannot guarantee it.

  • Over-the-Counter Tinnitus Medications and Drops: What the Labels Don’t Tell You

    Over-the-Counter Tinnitus Medications and Drops: What the Labels Don’t Tell You

    When you are standing in a pharmacy aisle, or scrolling through Amazon at midnight, and a box promises “#1 ENT Doctor Recommended” relief from the ringing in your ears, it is hard not to reach for it. You are not being foolish. You are responding to packaging designed by professionals who know exactly how desperate tinnitus can make a person.

    No over-the-counter tinnitus supplement or ear drop is FDA-approved for tinnitus. A 2019 Stanford analysis found that every OTC tinnitus product examined made unfounded relief claims, and some OTC ear drops contain ingredients that can worsen tinnitus. This article decodes what that packaging is legally allowed to say, what the evidence behind it actually shows, and where the real risks hide. The core findings may be frustrating: no over-the-counter tinnitus medication is FDA-approved, clinical evidence for every major OTC tinnitus supplement is either absent or negative, and some OTC ear drops contain ingredients that could make tinnitus worse. Knowing this now saves you money, protects your hearing, and points you toward options that do have evidence behind them.

    Tinnitus medication over the counter: the direct answer

    No over-the-counter tinnitus supplement or ear drop is FDA-approved for tinnitus. A 2019 Stanford analysis found that every OTC tinnitus product examined made unfounded claims of relief, with common vitamins and minerals repackaged at a significant price premium (Vendra et al., 2019). Some OTC ear drops marketed for tinnitus contain ingredients such as quinine derivatives and homeopathic mercury, which are associated with ototoxicity (damage to the inner ear or auditory nerve that can cause or worsen hearing loss and tinnitus) at therapeutic doses. If you are looking for a product that has cleared rigorous clinical testing for tinnitus relief, no such product currently exists on pharmacy shelves.

    How the law lets labels mislead you: the DSHEA loophole

    The reason supplement packaging can make such confident-sounding claims without proof comes down to a 1994 US law: the Dietary Supplement Health and Education Act, known as DSHEA. Under DSHEA, supplements are not required to obtain FDA pre-market approval. A manufacturer does not need to demonstrate that a product works before selling it. The FDA can only act after a product is already on the market, and only if it can prove the product is unsafe.

    DSHEA does allow one category of marketing claim, called a “structure/function” claim. This is the language behind phrases like “supports inner ear health” or “promotes healthy auditory function.” These statements are not drug claims, which would require proof of efficacy. They are claims about how a product might theoretically support a normal body process, and they require no clinical evidence to substantiate. This is how OTC tinnitus supplements can make confident-sounding claims without clinical proof.

    The law does require one safeguard: a disclaimer stating that “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.” Look for it in small print, usually on the back label, often in a font size that takes deliberate effort to read.

    That disclaimer is the single most important sentence on the packaging. It signals that the claims on the front of the box have not been tested or approved by any regulatory body. A product that says “supports relief from ear ringing” on the front and carries this disclaimer on the back is legally telling you, in two different font sizes, that the FDA has not confirmed it does anything for tinnitus.

    A 2019 Stanford market analysis found that every OTC tinnitus product examined used exactly this playbook: structure/function language, premium pricing, and the appearance of clinical endorsement, while selling ingredients available generically at a fraction of the cost (Vendra et al., 2019).

    Decoding the most common OTC tinnitus products

    Lipo-Flavonoid

    Lipo-Flavonoid is probably the most heavily marketed OTC tinnitus supplement in the United States. Its packaging has prominently featured the phrase “#1 ENT Doctor Recommended” for years.

    In December 2015, the National Advertising Division (NAD) investigated that claim and found it unsubstantiated. The underlying physician survey, it turned out, had asked only about the product’s use as an adjunct treatment for tinnitus associated with Meniere’s disease (an inner ear disorder causing vertigo, hearing loss, and tinnitus), not tinnitus in general. The brand appealed to the National Advertising Review Board (NARB), which upheld the core finding: Clarion’s supporting studies “failed to meet even the more lenient [FTC/FDA] requirement” (NAD Case #5977, December 2015; NARB Appeal #241). The NARB permitted only the much weaker claim that the product “may provide relief for some consumers who suffer from tinnitus.”

    The only independent, non-manufacturer-funded randomized controlled trial of Lipo-Flavonoid enrolled 40 participants. After dropouts, 28 completed the study. In the Lipo-Flavonoid-only control group (16 participants), zero patients showed a decrease in tinnitus questionnaire ratings. The researchers concluded: “We were not able to conclude that either manganese or Lipoflavonoid Plus is an effective treatment for tinnitus” (Rojas-Roncancio et al., 2016).

    A manufacturer-funded study later cited in product marketing was analyzed by an independent critic who found a completion rate of around 7%, meaning the vast majority of enrolled participants did not finish the study. Per the dossier’s caveats, this figure comes from a third-party analyst rather than a peer-reviewed source, so it should be read as a reported concern rather than an established finding. What is documented is that this study was not indexed in PubMed and was conducted by a single author with undisclosed industry ties.

    As of November 2025, a class-action lawsuit against Lipo-Flavonoid alleges deceptive marketing of the “#1 ENT Doctor Recommended” and “Clinically Shown to Help Manage Ear Ringing” claims, referencing the prior NAD and NARB rulings (South Shore Press, 2025).

    Ginkgo biloba (including products like Arches Tinnitus Formula)

    Ginkgo biloba is the most studied supplement for tinnitus. The verdict from that research is clear: it does not work. A 2022 Cochrane systematic review pooled results from 12 randomized controlled trials involving 1,915 participants. Ginkgo biloba showed little to no effect compared to placebo on tinnitus severity at 3 to 6 months, with a mean difference of -1.35 on a 0-to-100 scale (very low certainty evidence) (Sereda et al., 2022). The American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) clinical practice guideline explicitly recommends against using ginkgo biloba for persistent, bothersome tinnitus.

    Ginkgo is not risk-free. It can increase bleeding risk, particularly in people taking anticoagulants or antiplatelet medications. Talk to your doctor before taking it, especially if you are on blood thinners.

    Zinc supplements

    Zinc has been proposed as a tinnitus remedy based on the observation that some people with tinnitus have lower zinc levels. A 2016 Cochrane review of 3 randomized controlled trials involving 209 participants found “no evidence that the use of oral zinc supplementation improves symptoms in adults with tinnitus” (Person et al., 2016). In the largest of those trials (with 93 and 94 participants analysed per group), the improvement rate was 5% in the zinc group versus 2% in the placebo group, a difference that was not statistically significant. Zinc may have a role if a laboratory test confirms deficiency, but there is no evidence for routine supplementation. If you are already taking zinc supplements, be aware that high-dose zinc over the long term carries toxicity risk; do not exceed recommended amounts without medical supervision.

    Melatonin

    Melatonin is sometimes positioned as a tinnitus treatment because tinnitus and sleep disruption are closely linked. The AAO-HNS guideline recommends against melatonin as a tinnitus treatment. Some patients report that it helps with sleep, which is a genuine secondary burden of tinnitus, but there is no reliable evidence it reduces tinnitus loudness or severity directly. If sleep is your primary problem, a GP can discuss options with more evidence behind them. Note that melatonin can interact with sedative medications; if you are pregnant or taking sedatives, consult your doctor before use.

    OTC ear drops for tinnitus: a specific warning

    Ear drops occupy a different place in the mental category of OTC products. They come in small clinical-looking bottles, they are applied directly to the ear, and they feel more “medical” than a capsule. That feeling is not supported by the evidence.

    Two commonly found homeopathic ear drops marketed for tinnitus carry specific ingredient concerns. Ring Relief ear drops contain Mercurius solubilis, a homeopathic preparation derived from mercury, confirmed on the product’s DailyMed label. Similasan Ear Ringing Remedy contains a homeopathic preparation from Cinchona officinalis, the plant source of quinine. Quinine at therapeutic doses is classified as a Major Potential Hazard for tinnitus patients, with approximately 20% of patients on therapeutic doses experiencing ototoxic effects.

    The important caveat here: homeopathic dilutions are extremely high dilutions, and at the concentrations used in these products (12X, 13X, 15X), the amount of active substance is negligible or effectively zero by standard chemistry. The documented ototoxicity of quinine and mercury applies to therapeutic doses, not homeopathic dilutions. The clinical risk from these specific drops is not established in the evidence.

    The concern worth holding onto is this: these are products marketed for tinnitus relief, containing no evidence of efficacy, manufactured from known ototoxic agents, and sold under a regulatory framework that required no safety testing relative to tinnitus specifically. “Homeopathic” on a label is not a quality signal. It means the product bypassed standard evidence requirements entirely. If you have a perforated eardrum, the risks of any ear drop increase further.

    Check with a pharmacist before using any OTC ear drop for tinnitus.

    The label-reading checklist: 5 red flags to spot

    Once you know the playbook, you can read the packaging differently. Here are five patterns to look for.

    1. The structure/function disclaimer is on the back in small print. If you see “This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease,” the claims on the front of the box have no regulatory backing. This disclaimer is legally required, but most people never read it.

    2. “#1 doctor recommended” without a cited methodology. As the Lipo-Flavonoid case illustrates, this kind of claim can be based on a survey question about a different condition entirely. Ask: which doctors, how many, and what were they actually asked?

    3. “Clinically proven” without a named study. A claim is only as strong as the study behind it. Look for whether a specific peer-reviewed, placebo-controlled trial is named. If not, the phrase means very little.

    4. A money-back guarantee framed around 60 or 90 days. This framing implies results take long enough that most people will not bother with the administrative process of claiming a refund. It is a retention mechanism, not a quality signal.

    5. The ingredient list is a common vitamin stack. A 2019 Stanford analysis found that OTC tinnitus supplements typically consist of inexpensive, widely available vitamins, minerals, and herbs sold at a significant price premium when repackaged with tinnitus branding (Vendra et al., 2019). Check the generic equivalent price before buying.

    Spotting these patterns takes practice. If you have already spent money on products that used them, you were responding to marketing that was specifically designed to be persuasive. That is not a character flaw.

    If you are taking any anticoagulant or antiplatelet medication, check with your doctor before using any supplement containing ginkgo biloba. Ginkgo can increase bleeding risk and may interact with blood thinners.

    No OTC tinnitus supplement or ear drop is FDA-approved. Every major supplement category has been tested and found ineffective in controlled trials. Some OTC ear drops contain homeopathic preparations of known ototoxic agents. The regulatory framework allows confident-sounding claims without proof.

    Conclusion: where to put that money instead

    A page full of “this does not work” findings is hard to sit with when the ringing has not stopped. Knowing the dead ends is genuinely useful, though: it saves real money, protects your hearing, and redirects hope toward options with actual evidence behind them.

    The treatments that have cleared rigorous clinical testing are not in a pharmacy aisle. Cognitive behavioral therapy for tinnitus distress has endorsement from the AAO-HNS, NICE, and major international guidelines, with a Cochrane meta-analysis finding meaningful reductions in tinnitus distress. For people with co-occurring hearing loss, hearing aids often reduce the perceptual burden of tinnitus significantly. Sound therapy, including white noise and structured sound enrichment, is recommended in clinical guidelines as a management tool.

    The highest-value next step is a referral to a GP or audiologist. A clinician can assess whether there is an underlying cause, check for hearing loss, and point you toward evidence-based care. No supplement can do any of that.

    You deserve straight answers about what is and is not worth trying. The label did not give you those answers. This article aimed to.

  • Tinnitus Research Digest: Mental Health Burden, Integrated Care, and Medication-Linked Cases

    This week’s digest covers four areas relevant to tinnitus patients and clinicians: a cross-sectional study on mental health burden in tinnitus clinic attendees, a small pilot trial of an integrated management framework, a case report on pulsatile tinnitus linked to an acne medication, and an educational case report on Ménière’s disease. No single item represents a treatment advance, but together they reflect the importance of addressing tinnitus as a condition with psychological, audiological, and medical dimensions.

  • Tinnitus in Older Adults: Managing With Age-Related Hearing Changes

    Tinnitus in Older Adults: Managing With Age-Related Hearing Changes

    When Ringing Ears Feel Like One More Thing to Deal With

    About 1 in 5 older adults has tinnitus, and when it coexists with age-related hearing loss, fitting hearing aids is the single most impactful first step. A large population study found that hearing impairment roughly doubles the odds of tinnitus (OR 2.27), and evidence shows that hearing aids reduce tinnitus burden, improve sleep quality, and may help protect cognitive function (Oosterloo et al. (2021)). If you are an older adult dealing with tinnitus, or supporting someone who is, the good news is that practical, evidence-backed steps exist.

    When Ringing Ears Feel Like One More Thing to Deal With

    Tinnitus arrives for many older adults at a time when life already feels noisier with health concerns: a hearing test that didn’t go quite as hoped, nights that are harder to get through, and conversations that take more effort than they used to. A persistent ringing or buzzing on top of all that can feel overwhelming, and it is completely understandable if it does.

    What this article addresses is what makes managing tinnitus in later life different from managing it at 40 — the specific challenges that standard advice tends to skip over, the evidence behind hearing aids as more than a hearing device, and the practical steps that are most likely to make a real difference for this age group.

    Why Tinnitus Is More Common — But Not Inevitable — in Older Adults

    The most common reason tinnitus develops in older adults is age-related hearing loss, also called presbycusis. Over time, the tiny hair cells in the inner ear that convert sound waves into electrical signals gradually deteriorate. As the auditory signal reaching the brain weakens, the brain compensates by turning up its own internal sensitivity — a process researchers call central gain. The result can be phantom sounds: ringing, buzzing, or hissing that has no external source.

    A large Rotterdam Study of 6,098 older adults found that roughly 1 in 5 (21.4%) had tinnitus, and that having measurable hearing loss more than doubled the odds of experiencing it (OR 2.27) (Oosterloo et al. (2021)). Cardiovascular changes that come with age — reduced blood flow to the inner ear — and exposure to certain medications can also play a role, as discussed below.

    Here is the part that surprises many people: in the same study, tinnitus prevalence was roughly flat across different age groups within the older adult population, despite the fact that hearing loss increases steadily with age. Tinnitus is closely associated with ageing, but it is not simply an inevitable consequence of getting older (Oosterloo et al. (2021)). That distinction matters: it means there are factors you can address, rather than just a clock you cannot stop.

    Some causes are reversible. A build-up of earwax is a common and easily treated contributor — a GP or nurse can clear it quickly. Some medications can cause or worsen tinnitus (more on this below), and adjusting them under medical supervision sometimes reduces symptoms. Other contributors, like the gradual loss of cochlear hair cells, are not reversible, but the tinnitus that results from them is still very manageable.

    Tinnitus is common in older adults, but not inevitable. Hearing loss roughly doubles the risk — and some causes, such as earwax build-up or certain medications, are reversible.

    The Extra Challenges Older Adults Face

    General tinnitus advice — reduce stress, try white noise at night, see a specialist — is reasonable, but it does not capture three specific challenges that make tinnitus harder to manage in later life.

    Polypharmacy and ototoxic medications

    Many older adults take several medications simultaneously, and a significant number of commonly prescribed drugs can affect hearing or worsen tinnitus. A large US study (the Beaver Dam Offspring Study) found that 84 to 91% of older adults were taking at least one medication with ototoxic potential — among them, NSAIDs (such as ibuprofen and aspirin) taken by around 75%, and loop diuretics by around 35.6% of participants. Certain antibiotics (particularly aminoglycosides) and some chemotherapy agents also carry ototoxic risk.

    This does not mean these medications should be stopped. Many are prescribed for serious conditions, and the benefits will often outweigh the risk. The practical step is to raise the question with your GP: ask whether any current medications could be contributing to your tinnitus, and whether alternatives exist. Framing it as a medication review question — rather than asking to stop any particular drug — is usually the most productive approach.

    Never stop or reduce a prescribed medication because of tinnitus without speaking to your GP first. Some ototoxic medications treat conditions where stopping suddenly carries serious health risks.

    Sleep disruption

    Sleep quality tends to become more fragile with age regardless of tinnitus. Add a persistent ringing to already-lighter sleep architecture, and the effect compounds quickly. A meta-analysis of seven studies involving more than 3,000 tinnitus patients found that roughly 53.5% experienced sleep impairment (Gu et al. (2022)). While that figure covers adults of all ages and the study had high variability across its samples, objective data from the Rotterdam cohort specifically in older adults confirmed the relationship: tinnitus was independently associated with longer sleep onset latency, and in people with both tinnitus and hearing loss, circadian rhythm stability was also affected (de et al. (2023)).

    The quiet of the bedroom amplifies tinnitus perception, making it harder to fall asleep. Practical measures — keeping a low background sound playing overnight, maintaining a consistent sleep schedule, and avoiding complete silence at bedtime — can reduce how much the sound intrudes at the moment it matters most.

    Social withdrawal and isolation

    When hearing difficulty and tinnitus combine, social situations become genuinely exhausting. Following a conversation in a noisy room requires enormous effort; tinnitus adds an unwanted layer of sound that competes with speech. Over time, many people quietly reduce how often they socialise — fewer gatherings, less television, sometimes separate sleeping arrangements. These adaptations make sense in the short term, but sustained social withdrawal carries its own risks.

    Some research suggests that the combination of hearing loss, tinnitus, and the social isolation they can produce is associated with increased cognitive load and may contribute to accelerated cognitive decline in older adults (Jafari et al. (2019)). The connection is not fully established — longitudinal studies are still needed to confirm the causal direction — but it is a meaningful reason to treat tinnitus and hearing loss actively rather than simply accepting them.

    Hearing Aids: Not Just for Hearing

    For older adults who have both tinnitus and age-related hearing loss, hearing aids are the most evidence-backed intervention available — and they work on multiple levels, not just amplification.

    By restoring auditory input, hearing aids reduce the brain’s compensatory over-amplification that contributes to tinnitus. The resulting sound enrichment makes tinnitus less salient in everyday life: when there is more genuine sound to process, the phantom sound fades into the background. Many current hearing aid models also include built-in tinnitus masking features — programmable sounds that provide additional relief, particularly at night or in quiet environments.

    A prospective study of 100 patients fitted with hearing aids found that the group with both tinnitus and hearing loss showed significantly larger improvements than the hearing-loss-only group in two specific areas: working memory (assessed via Reading Span test, p less than 0.001) and sleep quality (assessed via the Pittsburgh Sleep Quality Index, p less than 0.001) (Zarenoe et al. (2017)). These were not marginal gains. Tinnitus severity scores also improved significantly at follow-up compared with baseline.

    There is also a broader cognitive health angle. Some research suggests that treating hearing loss with hearing aids may help reduce cognitive decline, particularly in people at higher baseline risk (Jafari et al. (2019)). A secondary analysis of a large US trial (ACHIEVE 2025) found that hearing aid use was associated with 62% slower cognitive decline in the highest-risk quartile of participants. This was a post-hoc subgroup analysis, so it should not be taken as definitive — but it points in a consistent direction, and a systematic review found that auditory amplification can improve cognition and quality of life alongside tinnitus burden (Malesci et al. (2021)).

    The referral path for hearing aids in the UK runs through your GP or directly to an NHS audiology service. A hearing assessment is the starting point. Private audiology clinics are also widely available for those who prefer faster access. If you are supporting an older relative who resists hearing aids because of stigma or cost concerns, the dual-benefit evidence — sleep, cognition, and tinnitus relief alongside better hearing — is worth sharing. Modern aids are considerably smaller and less conspicuous than older designs.

    One of the things patients with both tinnitus and hearing loss often say after being fitted with hearing aids is that they had not realised how much the combination was affecting their sleep and concentration. The improvement in tinnitus can feel like a side effect — a welcome one.

    Other Management Approaches That Work for Older Adults

    Hearing aids are the most evidence-backed starting point when hearing loss is present, but they are not the only option — and not every older adult with tinnitus has significant hearing loss.

    Sound enrichment at home

    Tabletop white noise machines, a radio playing softly at low volume, or smartphone apps that generate ambient sound (rain, a fan, nature sounds) can all reduce tinnitus salience — particularly at night. The principle is the same as with hearing aids: providing background sound makes the phantom noise less dominant. This is a low-barrier first step for anyone not yet fitted with hearing aids or waiting for an audiology appointment. The Cochrane review on sound therapy found clinically meaningful within-group improvements in tinnitus severity for people using amplification and sound enrichment devices, though it could not establish superiority over other active interventions (Sereda et al. (2018)).

    Cognitive behavioural therapy and TRT

    Cognitive behavioural therapy (CBT) is well-established for reducing tinnitus distress and is recommended in clinical guidelines. CBT does not reduce the volume of tinnitus, but it addresses the distress and the habitual attention that makes tinnitus disruptive. Evidence supporting CBT for tinnitus generally is solid, though age-specific trials are limited. CBT adapted for older adults can be delivered in-person or digitally, making it accessible to those with mobility constraints or limited travel options. Tinnitus Retraining Therapy (TRT) combines sound therapy with structured counselling and is also available through specialist audiology services in many areas.

    Access to these therapies varies by region. In England, a GP referral to an ENT or audiology service is typically the pathway to both.

    Cardiovascular and general health management

    Because reduced blood flow to the inner ear is a contributing factor in some age-related tinnitus, managing cardiovascular risk factors — blood pressure, exercise, diet — is a relevant background step. These are changes most older adults are already advised to make for other reasons; the tinnitus angle is simply one more reason they matter.

    Addressing sleep directly

    If sleep is significantly disrupted, treating that problem directly — rather than waiting for tinnitus to improve first — can break a reinforcing cycle. Avoiding complete silence at bedtime, maintaining consistent sleep and wake times, and limiting screen use before sleep are practical first steps. If sleep problems are severe, a GP can assess whether a sleep-specific referral is warranted.

    When to See a Doctor: Red Flags and Referral Paths

    Most tinnitus in older adults does not represent a medical emergency, but some presentations require prompt attention.

    Seek urgent help the same day or within 24 hours if:

    • Tinnitus has come on suddenly alongside a sudden drop in hearing (within the last 30 days)
    • You notice any sudden change in facial sensation or movement alongside tinnitus

    See your GP within one to two weeks if:

    • Tinnitus is getting rapidly worse
    • It is causing significant distress that affects daily activities

    Arrange a routine GP appointment if:

    • Tinnitus is in one ear only
    • Tinnitus is pulsatile (beating in time with your heartbeat)
    • Tinnitus is persistent and new, especially with no obvious cause

    All of these thresholds are consistent with NICE clinical guideline NG155, which recommends audiological assessment for all patients presenting with tinnitus (National (2020)).

    For any older adult with new tinnitus, a hearing test is a sensible baseline step even if the tinnitus feels mild. It establishes whether hearing loss is present and whether hearing aids would help. The usual pathway in the UK is GP to audiology or ENT, and NHS audiology departments can assess and fit aids without a specialist referral in many areas.

    Research suggests that older women in particular may be less likely to have tinnitus investigated, so if you feel your concerns have been dismissed, it is worth being direct with your GP about requesting a hearing assessment and onward referral.

    Tinnitus in Later Life Is Manageable — Start With Your Hearing

    Tinnitus is common in older adults, but it is not something you simply have to accept without support. Hearing loss is the most actionable risk factor: addressing it with hearing aids can reduce tinnitus burden, improve sleep, and may support cognitive health over time. Sound enrichment, CBT-based approaches, and a medication review with your GP round out a practical set of tools that go well beyond simply putting up with the noise.

    If you are not sure where to start, a conversation with your GP and a hearing assessment are the two most concrete steps you can take today. From there, the right combination of support can be shaped around what matters most to you.

  • Medications That Cause Tinnitus: The Complete Ototoxicity Guide

    Medications That Cause Tinnitus: The Complete Ototoxicity Guide

    Could Your Medication Be Causing That Ringing?

    Realising that a medication you depend on might be responsible for a new ringing or buzzing in your ears can feel unsettling. You’re not imagining it, and you’re not alone in making that connection. Drug-induced tinnitus is one of the few forms of tinnitus with a clearly identifiable cause, and that is genuinely useful information. Knowing which drug class is involved tells you a great deal about whether the tinnitus is likely to resolve, and what your next step should be. This article walks through the major drug classes, what reversibility actually means for each, and a clear action plan.

    Which Medications Can Cause Tinnitus?

    Over 200 medications are classified as ototoxic, but the most important distinction for patients is reversibility: tinnitus from high-dose aspirin or NSAIDs typically resolves when the drug is stopped, while damage from aminoglycoside antibiotics and cisplatin chemotherapy is often permanent, making new tinnitus during these treatments an urgent reason to contact your prescriber (Seligmann et al. (1996)).

    The major drug classes linked to tinnitus include:

    • High-dose aspirin and salicylates — the most commonly encountered reversible cause
    • NSAIDs (ibuprofen, naproxen, diclofenac) — reversible at high or prolonged doses
    • Aminoglycoside antibiotics (gentamicin, tobramycin, amikacin, neomycin) — risk of permanent damage
    • Platinum-based chemotherapy (cisplatin, carboplatin) — high risk of permanent damage
    • Loop diuretics (furosemide, ethacrynic acid) — variable; route and dose matter significantly
    • Antimalarials (quinine, chloroquine) — typically reversible
    • Macrolide antibiotics (azithromycin, erythromycin, clarithromycin) — elevated risk confirmed by recent large-scale evidence
    • Certain cardiac and psychotropic drugs — less common; class-dependent reversibility

    The word “ototoxic” simply means toxic to the inner ear. Tinnitus is often the earliest sign — it can appear before any measurable change in your hearing shows up on a standard test (Seligmann et al. (1996)).

    The Reversibility Divide: Temporary vs. Permanent Risk

    Understanding reversibility comes down to one biological fact: human cochlear hair cells do not regenerate. When a drug kills them, that damage is permanent. When a drug temporarily disrupts their function without killing them, the effect can reverse once the drug is cleared.

    Typically reversible

    High-dose aspirin and salicylates work by inhibiting prostaglandin synthesis in the cochlea, which disrupts the function of prestin — a motor protein in outer hair cells. The cells are not destroyed; they are temporarily altered. Aspirin-induced tinnitus generally requires doses of around 2,000 mg per day or more before cochlear effects appear (Federspil (1990)). Reduce the dose or stop the drug, and the tinnitus typically clears. Standard low-dose aspirin (75–100 mg) used for cardiovascular prevention does not carry this risk: a large cohort study of 69,455 women found that low-dose aspirin use was not associated with increased tinnitus risk (Curhan et al., as cited in the research evidence base).

    NSAIDs at high or sustained doses carry a similar, dose-dependent mechanism. The risk is most relevant for people taking NSAIDs regularly at high doses for chronic pain, not those taking occasional standard doses for a headache.

    Quinine and antimalarials cause tinnitus through a mechanism that also disrupts outer hair cell function without permanent destruction in most cases. Tinnitus from these drugs is typically reversible, though no modern controlled trial has confirmed precise reversal rates — hedge your expectations accordingly.

    Risk of permanent damage

    Aminoglycoside antibiotics are selectively taken up by cochlear outer hair cells, where they generate reactive oxygen species that cause irreversible cell death (Federspil (1990)). Tinnitus rates across studies range from 0–53% depending on dose, duration, and co-exposures (Diepstraten et al. (2021)). The damage does not reverse when the antibiotic is stopped, because the cells are gone.

    Cisplatin and carboplatin destroy cochlear hair cells through a combination of direct DNA damage and oxidative stress, beginning at frequencies above 6,000 Hz and progressing toward speech frequencies over time. Published literature reports hearing impairment in up to 80% of treated patients in some series, with the effect continuing or worsening after treatment ends (Janowiak-Majeranowska et al. (2024)). Delayed onset — where hearing worsens months after the last dose — has been documented, with monitoring recommended for up to 10 years post-treatment.

    Ethacrynic acid (a loop diuretic) combined with aminoglycosides is a particularly high-risk combination: the two drugs act synergistically, causing more damage together than either would alone.

    Tinnitus as an Early Warning Sign: Why You Should Act Fast

    Here is something that most articles on this topic leave out, and it matters practically.

    Ototoxic damage follows a predictable sequence. It begins at the highest frequencies, typically 8,000 Hz and above, well outside the range of normal conversation. Standard hearing tests — the kind done in most clinics — only measure 250 to 8,000 Hz. This means that by the time a routine audiogram catches a problem, meaningful cochlear damage may already have occurred (Campbell & Le (2018)).

    Tinnitus often appears before that threshold is crossed. It is the cochlea signalling distress before the damage has extended into the range a standard test will detect. For patients on aminoglycosides, cisplatin, or high-dose IV loop diuretics, new tinnitus is not a side effect to quietly endure — it is a reason to contact your prescriber the same day.

    The American Speech-Language-Hearing Association’s guidelines state clearly: if any symptoms of cochlear toxicity arise during treatment with these drugs, the physician must be notified immediately (ASHA (1994)). Extended high-frequency audiometry, which tests above the standard 8,000 Hz ceiling, can detect early damage in time for a clinical response.

    This is not meant to cause alarm. The point is the opposite: catching a signal early gives you and your clinical team options. Waiting to see whether things improve on their own is the approach most likely to result in avoidable, permanent damage.

    If you develop new tinnitus while taking cisplatin, aminoglycoside antibiotics, or high-dose intravenous diuretics, contact your prescriber promptly — do not wait for a routine appointment.

    What Increases Your Risk? Factors That Amplify Ototoxicity

    Not everyone exposed to an ototoxic medication develops tinnitus or hearing loss. Several factors increase the probability of cochlear damage:

    • Kidney impairment. Many ototoxic drugs are cleared by the kidneys. When kidney function is reduced, drug levels in the blood accumulate higher and remain elevated longer, increasing cochlear exposure. This applies particularly to aminoglycosides and loop diuretics (Seligmann et al. (1996)).
    • Combining ototoxic drugs. Taking an aminoglycoside antibiotic alongside a loop diuretic is the classic high-risk combination — the two drugs interact synergistically, and the resulting cochlear damage is greater than either drug alone would produce (Federspil (1990)).
    • Dose and duration. Higher doses and longer courses of treatment consistently increase ototoxic risk across all classes. This is one reason regular audiological monitoring is recommended for patients on extended courses of cisplatin or aminoglycosides.
    • Intravenous bolus delivery. With loop diuretics, how the drug is delivered matters. A rapid intravenous bolus carries meaningfully higher ototoxic risk than slow IV infusion or oral dosing, because peak drug concentrations in cochlear fluid are much higher (Federspil (1990)).
    • Genetic susceptibility. Some people carry a variant in the MT-RNR1 mitochondrial gene that dramatically increases sensitivity to aminoglycoside antibiotics. If you or a family member has had severe hearing loss after a short course of antibiotics, this is worth raising with your doctor before any future aminoglycoside treatment (May et al. (2023)).

    The combination of kidney impairment, an aminoglycoside antibiotic, and a loop diuretic carries the highest known ototoxic risk. If you are in this situation, ask your prescriber whether all three are necessary simultaneously.

    What Should You Do If You Think Your Medication Is Causing Tinnitus?

    The most important rule first: do not stop a prescribed medication without speaking to your prescriber. The American Tinnitus Association puts it directly — the risk of stopping a medication may far exceed any potential benefit from reducing the tinnitus. This is especially true for antibiotics treating active infection, chemotherapy, or medications managing a serious cardiovascular or neurological condition.

    Here is a practical sequence:

    Step 1: Note the timeline. Write down when the tinnitus started, whether it appeared shortly after beginning the medication or after a dose increase, and whether it is constant, intermittent, or changing. This information will help your prescriber assess the likelihood of a drug link.

    Step 2: Contact your prescriber promptly. Do not wait for a routine follow-up if the tinnitus started during a course of aminoglycosides, cisplatin, or high-dose IV diuretics. For OTC medications (ibuprofen, aspirin), a call to your GP is appropriate rather than emergency contact.

    Step 3: Ask about audiological monitoring. If you are on a cisplatin or aminoglycoside course, ask your prescriber whether baseline extended high-frequency audiometry was arranged. ASHA guidelines recommend this be done before or within 72 hours of the first aminoglycoside dose, and no later than 24 hours after the first cisplatin dose (ASHA (1994)). If monitoring was not arranged, ask now.

    Step 4: Ask about alternatives. If the ototoxic drug is being used for a non-urgent or non-critical indication, ask your prescriber whether a lower-risk alternative exists. This is a reasonable question and a good prescriber will not be offended by it.

    A note on OTC medications: ibuprofen and aspirin taken at standard doses for occasional pain rarely cause tinnitus. The risk emerges with long-term moderate-to-high dose use. If you take NSAIDs or aspirin regularly, this is worth mentioning to your GP at your next appointment.

    If you develop tinnitus while taking a prescribed medication, your instinct may be to stop the drug immediately. Resist that impulse. Contact your prescriber first — they can assess whether the drug is the cause and whether a safer alternative exists.

    Key Takeaways: What Matters Most

    Three things worth remembering from everything above:

    First, many medications linked to tinnitus — particularly OTC painkillers like ibuprofen and aspirin at non-prescription doses — cause tinnitus that is reversible when the dose is reduced or stopped. The risk at standard doses is low.

    Second, tinnitus during a course of aminoglycoside antibiotics, cisplatin, or high-dose intravenous diuretics is an early warning that warrants same-day contact with your prescriber. These drugs can cause permanent cochlear damage, and tinnitus often appears before that damage becomes detectable on a standard hearing test.

    Third, never stop a prescribed medication on your own. Always involve your prescribing doctor or specialist.

    Drug-induced tinnitus is one of the most actionable forms of tinnitus — because it has an identifiable cause. Knowing which drugs carry risk, understanding what reversibility means in practice, and knowing when to act puts you in a much stronger position than most people who experience tinnitus onset. That knowledge is the point of this article.

  • Your First Audiologist Appointment for Tinnitus: What to Expect

    Your First Audiologist Appointment for Tinnitus: What to Expect

    Before You Walk In: What’s Going Through Your Head

    If you have been hearing a sound that nobody else can hear — ringing, buzzing, hissing, or something else entirely — and you have finally booked an appointment with an audiologist, you are probably carrying a lot of questions into that waiting room. Will they find something? Will everything come back normal, and what does that even mean? Will you leave with answers, or just more uncertainty?

    Those fears are understandable. This article walks you through exactly what happens at a first tinnitus appointment with an audiologist: what you will be asked, what the tests involve, what the results mean, and what a normal finding actually tells you. By the end, you should feel less like you are walking into the unknown and more like someone with a clear picture of what to expect.

    What Does an Audiologist Actually Do for Tinnitus?

    At your first audiologist appointment for tinnitus, expect a detailed case history, a comprehensive hearing test, and tinnitus-specific assessments covering pitch and loudness matching. The full evaluation typically lasts 60–90 minutes and ends with a personalised management plan, even if no single cause is identified. Audiologists check for co-existing hearing loss — present in roughly 90% of chronic tinnitus cases (Shapiro, 2021) — rule out causes that need onward referral, and build an individual plan covering sound therapy, hearing aids, or psychological support. The goal is not a cure but a clear understanding of your tinnitus and a concrete next step.

    Step 1 — Before Your Appointment: How to Prepare

    A little preparation before you go makes the case history faster and ensures the audiologist gets accurate information from the start.

    What to write down before your appointment:

    • When the tinnitus started and how it began (suddenly or gradually)
    • What the sound is like: ringing, buzzing, hissing, clicking, or a tone
    • Which ear or ears are affected, or whether it feels like it is inside the head
    • Whether it is constant or comes and goes, and if anything makes it better or worse
    • Any recent noise exposure — a concert, power tools, a workplace incident
    • Any recent ear infections, head or neck injuries, or periods of intense stress

    Compile a full list of medications and supplements. Some drugs are ototoxic — capable of affecting hearing and potentially triggering or worsening tinnitus. These include salicylates (such as high-dose aspirin), loop diuretics, certain aminoglycoside antibiotics, and quinine-based medications (Merck Manual, S13). The audiologist will ask about these directly.

    Consider bringing a trusted person with you. Appointments covering new medical findings can be emotionally loaded, and it is easy to miss details when you are anxious. Having someone alongside to listen and take notes means you leave with a clearer picture of what was said (Silicon Valley Hearing, S14).

    Step 2 — The Case History: Questions You Will Be Asked

    The appointment typically begins with an in-depth conversation before any tests start. The audiologist is building a detailed picture of your tinnitus and the factors that might be driving it.

    Expect questions about: what the sound is like and how long you have had it; whether it is in one ear, both ears, or centrally located; whether it is steady or pulsing; what makes it louder or quieter; your history of noise exposure; any medical conditions such as high blood pressure, cardiovascular disease, jaw problems (TMJ issues can generate tinnitus), or a history of ear disease; and your full medication list.

    You will also be asked about sleep, concentration, mood, and anxiety. This is not small talk. Research shows that psychological distress — not audiological severity — is the strongest predictor of how much tinnitus affects daily life (Park et al., 2023). Two people with very similar audiograms can experience completely different levels of distress, and that matters for designing a management plan.

    The audiologist may give you a short questionnaire to complete — either the Tinnitus Handicap Inventory (THI) or the Tinnitus Functional Index (TFI). Both are validated clinical tools that measure how much tinnitus is affecting your quality of life across different areas: emotional wellbeing, concentration, sleep, and daily activities (Boecking et al., 2021). They are not a test you pass or fail. They establish a baseline so that any improvement — or worsening — can be tracked objectively over time.

    The case history phase typically takes 20–30 minutes. Arriving with notes means you spend less time trying to recall details under pressure and more time getting the conversation right.

    Step 3 — The Hearing Test: What Happens in the Sound Booth

    After the case history, you will move to an audiometric assessment — usually conducted in a small sound-treated booth or room designed to block background noise.

    For pure-tone audiometry, you will wear headphones and press a button (or raise a hand) each time you hear a tone. The tones vary in pitch and volume, mapping out the quietest sound you can detect across different frequencies. This is the standard hearing test most people have encountered at some point. It checks hearing across the 250–8,000 Hz range.

    The audiologist will also carry out tinnitus-specific measurements. Pitch matching involves playing tones until you identify one that sounds closest to your tinnitus — this helps characterise the tinnitus frequency. Loudness matching establishes how loud the tinnitus appears to you relative to external sounds; most patients are surprised to discover their tinnitus registers as only a few decibels above their hearing threshold in that frequency range, even when it feels much louder (American, S5). The audiologist may also measure the minimum masking level — the softest external sound needed to cover the tinnitus — which informs sound therapy decisions.

    Tympanometry may also be performed, particularly if middle-ear dysfunction or Eustachian tube problems are suspected. This test uses a small probe to measure how well the eardrum moves, checking for fluid or pressure issues in the middle ear (National, 2020).

    Hearing loss is present in roughly 90% of people with chronic tinnitus (Shapiro, 2021). Identifying it — and its pattern across frequencies — is one of the most important steps in building a management plan.

    Step 4 — The Results and Management Plan: What Happens Next

    After testing, the audiologist will sit with you and go through the findings. They will explain what the hearing test shows, what the tinnitus measurements indicate, and what the options are from here.

    Depending on the findings, management options may include:

    • Sound therapy: background sound or white noise to reduce tinnitus contrast, particularly useful at night
    • Hearing aids: if hearing loss is present, restoring auditory input reduces the brain’s compensatory overactivity that drives tinnitus perception (Shapiro, 2021)
    • Referral to CBT or Tinnitus Retraining Therapy (TRT): for patients whose tinnitus is causing significant distress, structured psychological or habituation-based programmes have evidence behind them
    • Lifestyle and sleep guidance: practical steps for reducing the impact of tinnitus on daily life
    • Onward referral to ENT or neurology: if red flags are present (see the next section)

    Now for the question patients are most afraid to ask: what if the tests come back normal?

    A normal audiogram does not mean nothing is wrong. Standard pure-tone audiometry has known limitations for detecting subtle cochlear damage. A study of tinnitus patients with clinically normal hearing found that 75.6% had at least one measurable subclinical audiological abnormality when more detailed testing was used — and 35.4% had high-frequency hearing loss that standard tests did not capture (Park et al., 2023). A systematic review independently confirmed that standard audiometry cannot reliably detect hidden hearing loss or cochlear synaptopathy, a type of nerve damage that affects sound processing even when basic hearing thresholds appear intact (Barbee et al., 2018).

    A normal audiogram, in other words, is not a dismissal. It is a starting point. The VA/DoD Clinical Practice Guideline (2024) explicitly directs clinicians not to tell tinnitus patients ‘there is nothing you can do’ — because there is always a next step. Most patients leave the first appointment with a management plan, not a ‘wait and see.’

    Red Flags the Audiologist Will Watch For

    Part of the audiologist’s role is to identify findings that need specialist investigation. Understanding why certain questions are asked can make the process feel less mysterious.

    Red flags that would prompt onward referral include:

    • Tinnitus only in one ear (unilateral): could indicate a structural cause requiring imaging, such as an acoustic neuroma
    • Pulsatile tinnitus (rhythmic, in time with the heartbeat): may reflect a vascular cause and typically requires imaging, including MRI or Doppler assessment (AWMF, S7)
    • Sudden-onset tinnitus with hearing loss: possible sudden sensorineural hearing loss, which is treated as a medical urgency — prompt ENT referral is indicated (National, 2020)
    • Asymmetric hearing loss on audiogram: greater loss in one ear than the other warrants further investigation
    • Tinnitus accompanied by vertigo or neurological symptoms: may need specialist evaluation

    Identifying a red flag is not a bad outcome. It opens the path to targeted assessment and treatment. The large majority of patients presenting for a first tinnitus appointment will not have any of these findings.

    Key Takeaways: What to Remember

    • A first tinnitus appointment with an audiologist typically lasts 60–90 minutes and covers case history, a comprehensive hearing test, and tinnitus-specific assessments.
    • Roughly 90% of people with chronic tinnitus have some degree of co-existing hearing loss — the audiogram is one of the most important steps in the evaluation.
    • A normal audiogram does not mean ‘nothing is wrong’ — standard tests can miss cochlear damage that more detailed assessment would find (Park et al., 2023).
    • Red flags like pulsatile or one-sided tinnitus will be noted and referred appropriately — most people will not have them.
    • You should leave with a management plan and concrete next steps, not just an instruction to wait and see.

    The first appointment is not the end of the road. It is the point at which an audiologist starts helping you understand what is happening and what can be done about it — and that is a meaningful step forward, whatever the results show.

  • Tinnitus Research Digest: Acne Drug Warning, Somatosensory Assessment, and Brain Mechanism Reviews

    This week’s digest covers four distinct areas: a case report linking a common acne medication to pulsatile tinnitus, a clinical study mapping the physical dysfunctions found in somatosensory tinnitus patients, a cross-sectional study on morning blood pressure surges and tinnitus in hypertensive patients, and two mechanistic reviews examining the neurobiology of tinnitus and its relationship with sound intolerance. The clinical items have the clearest patient relevance; the reviews provide background context without immediate treatment implications.

Subscribe to Our Tinnitus Newsletter

  • Learn everything about tinnitus causes, myths, and treatments
  • Get the latest tinnitus research delivered to your inbox every week

You can unsubscribe anytime.

Subscribe Now